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specificity of molecular recognition.
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Disordered proteins are important antigens in a range
of infectious diseases. Little is known, however, about
the molecular details of recognition of disordered
antigens by their cognate antibodies. Using a large
dataset of protein antigens, we show that disordered
epitopes are as likely to be recognized by antibodies
as ordered epitopes. Moreover, the affinity with
which antigens are recognized is, unexpectedly,
only weakly dependent on the degree of disorder
within the epitope. Structurally defined complexes
of ordered and disordered protein antigens with their
cognate antibodies reveal that disordered epitopes
are smaller than their ordered counterparts, but are
more efficient in their interactions with antibody. Our
results demonstrate that disordered antigens are
bona fide targets of antibody recognition, and that
recognition of disordered epitopes is particularly sen-
sitive to epitope variation, a finding with implications
for the effects of disorder on the specificity of molec-
ular recognition more generally.
INTRODUCTION
There is an increasing recognition that many proteins naturally
lack a defined folded state, and that their function depends
instead on conformational disorder (Dunker et al., 2002; Wright
and Dyson, 2015). These intrinsically disordered proteins are
widespread in nature and are abundant in a range of pathogenic
organisms. Several parasite species have an unusually high pro-
portion of disordered proteins (Feng et al., 2006), and although
the extent of disorder in viral proteomes is highly variable,
some are predicted to be extensively disordered (Xue et al.,
2014). Nonetheless, the implications of protein disorder for im-
mune recognition by B cells and antibodies have received
remarkably little attention.
On the one hand, it has been suggested that intrinsically disor-
dered proteins will elicit weak immune responses or even be
completely non-immunogenic (Dunker et al., 2002). This argu-
ment is based in part on the fact that disordered proteins often
adopt relatively well-defined conformations when bound to part-
ner proteins or to antibodies, and that this is achieved by a pro-
cess of coupled folding and binding, which places both kinetic
and thermodynamic constraints on the interaction (Uversky,
2013). As a result, the interactions of disordered proteins are148 Structure 24, 148–157, January 5, 2016 ª2016 Elsevier Ltd All rigoften of relatively low affinity, despite maintaining high speci-
ficity. These properties are ideally suited to mediators of signals
that must be switched on or off rapidly, and, accordingly,
disorder is particularly common in proteins involved in signal
transduction (Wright and Dyson, 2015). They are quite distinct,
however, from the properties of typical antibody-antigen interac-
tions, which are selected for high affinity. Consistent with the
argument that disordered proteins may be poor immunogens,
it has been observed that functionally important sites on protein
antigens are often highly flexible, or are surrounded by flexible
loops (Colman, 1997; Kwong et al., 2002; MacRaild et al.,
2011); this flexibility is proposed to serve as a means of immune
evasion, with ‘‘conformational masking’’ being mediated by the
entropic cost of inducing order in the otherwise flexible antigen
(Kwong et al., 2002).
In sharp contrast, however, disordered antigens can be immu-
nodominant. In some instances these antigens, despite their im-
munodominance, fail to contribute to immune protection, and
thus are believed to function as a ‘‘smokescreen’’, diverting the
immune system from targets with greater protective potential
(Kemp et al., 1987). Nonetheless, numerous B-cell epitopes
have been characterized in disordered proteins, and many of
these appear to contribute to functional immune responses
and therefore represent potential vaccine candidates (Adda
et al., 2012; Foquet et al., 2014; Foucault et al., 2010; Olugbile
et al., 2009; Raj et al., 2014; Yagi et al., 2014). For example,
the protective effects of the most advanced malaria vaccine,
RTS,S, appear to be mediated by antibodies to the disordered
repeats of the circumsporozoite protein (Dyson et al., 1990; Fo-
quet et al., 2014).
To explore the implications of disorder for antibody recogni-
tion, we have examined the immune epitope database (IEDB)
(Vita et al., 2015) for the presence of antigens that are predicted
to be disordered. We find that disordered antigens are no less
likely than ordered antigens to be recognized by antibodies,
and that the affinity of the antibody-antigen interaction is only
weakly dependent on epitope disorder. Using a dataset of struc-
turally defined antibody-antigen complexes, we reveal structural
features that contribute to the unexpectedly high affinity of the
interactions between disordered antigens and their cognate
antibodies.RESULTS
Disordered Proteins Are Common Targets of Antibody
Responses
Although there is increasing awareness of the importance of
disordered antigens in the immune response to a number ofhts reserved
Figure 1. Disorder Is No Barrier to the Development of an Antibody
Response
(A) Disordered epitopes (red) are abundant in a dataset extracted from the
IEDB.
(B) The average fraction of IEDB B-cell assays that are positive for antibody
binding is higher for assays performed on epitopes that are predicted by
IUPred to be disordered (red), than those predicted to be ordered (blue) or to
contain a mix of both ordered and disordered residues (purple). Errors on the
mean are estimated by bootstrap resampling from the set of antigens. See also
Figure S1.
(C) The fraction of IEDB B-cell assays that are positive (black) and the average
relative SASA for residues in a non-redundant subset of the PDB (green),
plotted as a function of IUPred score.
(D) Antibody binding affinities reported in the IEDB for ordered (blue),
mixed (purple), and disordered (red) epitopes. Boxplots show the median
(horizontal line) and interquartile range (box), with whiskers extending to
1.5 times the interquartile range, and any outlying points plotted. See also
Dataset S1.pathogens, the capacity of disordered antigens to elicit a robust
immune response has been questioned (Dunker et al., 2002). To
address this issue, we used IUPred (Dosztanyi et al., 2005) to
assess the extent of disorder across a total of 1,946 protein an-
tigens for which five or more B-cell assays are reported in the
IEDB. Overall, 27.5% of residues (105,569 of 384,022) in this da-
taset are predicted to be disordered, a value comparable with
the extent of disorder observed in many eukaryotic proteomes,
and much higher than typically seen in prokaryotic or archaeal
proteomes. Of the 55,000 characterized linear epitopes in
these antigens, 6,858 (12.6%) are entirely within regions pre-
dicted by IUPred to be disordered, while 16,030 (29.4%) are
in mixed regions, that is, regions predicted to include both or-
dered and disordered residues (Figure 1A). Antibody binding
to these disordered epitopes has been assessed in almost
14,000 assays reported in the IEDB. Assays that involve disor-
dered epitopes report positive results for antibody binding
more frequently than do assays involving ordered or mixed epi-
topes (Figure 1B), implying that conformational disorder is not in
itself a barrier to the development of an antibody response.
Similar results are obtained using DISOPRED (Jones and Coz-Structure 24, 14zetto, 2015) as an alternative predictor of epitope disorder
(Figure S1).
To explore this further, we sorted the residues in our antigen
dataset according to their IUPred score, and assessed the rela-
tionship between IUPred score and the frequency with which B-
cell assays returned positive results. We find that this proxy for
antigenicity increases with increasing IUPred score over the ma-
jority of that scale (Figure 1C, black line). In other words, as the
predicted disorder of residues in this dataset increases, so
does the likelihood that B-cell assays involving those residues
will return a positive result for antibody binding. Given that
accessibility and IUPred score are expected to be correlated,
and taking into account the fact that the antigenicity of residues
in structured antigens is strongly dependent on the accessibility
of these residues (Novotny et al., 1986), this effect maymask any
negative impact of disorder on antigenicity. To test for this, we
examined a non-redundant set of protein structures from the
PDB (Berman et al., 2002) and assessed the relationship be-
tween relative solvent-accessible surface area (SASA) and
IUPred score for each residue in this dataset. We find that the
relationship between IUPred score and the average relative
SASA tracks the relationship between IUPred score and antige-
nicity in the IEDB dataset, except at very small IUPred scores
(Figure 1C). Both antigenicity (as measured by the frequency of
positive B-cell assays) and solvent exposure increase gradually
with IUPred score over the range 0.02–0.8, before increasing
more sharply at higher IUPred scores. This result confirms the
importance of solvent exposure as a key determinant of antige-
nicity (Novotny et al., 1986), and suggests that the dependence
of antigenicity on IUPred score may largely reflect the increase in
accessibility that accompanies increasing disorder. More impor-
tantly, it argues strongly against the suggestion that disordered
epitopes are markedly less likely to be targets of an antibody
response.
Antibody Affinity Is Only Weakly Influenced by Epitope
Disorder
It has been suggested that antibodies are unlikely to bind disor-
dered antigens with high affinity (Dunker et al., 2002), owing to
the entropic cost associated with the disorder-order transition
that accompanies binding (Dyson and Wright, 2002; Kwong
et al., 2002). In support of this argument, it is claimed that disor-
dered proteins and peptides bind with lower affinity to their bind-
ing partners. For example, there is a 25-fold difference in median
affinity between the protein-protein and protein-peptide com-
plexes in the dataset of Chen et al. (2013), while a 2 kcal/mol dif-
ference in average binding free energy (equivalent to an approx-
imately 30-fold affinity difference) was observed in a dataset of
disordered and ordered protein-protein interactions (Huang
and Liu, 2013). However, it is unclear to what extent we can
generalize from these datasets (Pancsa and Fuxreiter, 2012).
To examine the magnitude of this effect for antibody recognition,
we have identified those epitopes in our dataset for which affinity
measurements are reported in the IEDB. Across the 666 affinity
measurements reported for antibodies binding to 284 distinct
epitopes, the median affinity of antibodies for disordered epi-
topes is only 5-fold lower than that for ordered epitopes (Fig-
ure 1D). We observe only a weak correlation between affinity
and the average IUPred score for each epitope (Spearman’s8–157, January 5, 2016 ª2016 Elsevier Ltd All rights reserved 149
Figure 2. Disordered Epitopes Are Small, Continuous Epitopes
(A) The number of contact residues comprising both the antibody paratope (left) and the antigen epitope (right) is smaller for disordered epitopes (red) than for
ordered epitopes (blue).
(B) Antibody-antigen interactions involving ordered epitopes (blue) bury more surface area on the antibody (left) and the antigen (right) than do the interactions of
disordered epitopes (red).
(C) The distribution of epitope span, the minimum number of contiguous residues that contain all of the epitope, for ordered epitopes (blue) is bimodal, while
disordered epitopes (red) comprise only short, linear epitopes. The region of the distribution containing all disordered epitopes is shown at higher resolution
(inset).
Boxplots show the median (horizontal line) and interquartile range (box), with whiskers extending to 1.5 times the interquartile range, and any outlying points
plotted.r = 0.14), indicating that predicted epitope disorder accounts
for very little of the variation in antibody-antigen affinities in this
dataset. This runs counter to the widespread expectation that
the affinity of antibodies for disordered epitopes will be substan-
tially reduced. There are, however, several well-characterized
examples of high-affinity antibodies to disordered antigens
(Chi et al., 2007; Morales et al., 2015; Tetin et al., 2006), and
the modest difference in affinity characterized here is compara-
ble with the difference in average antibody dissociation rate
observed against representative ordered and disorderedmalaria
antigens in sera from malaria-exposed individuals (Reddy et al.,
2012).
To give context to this result, we find it instructive to consider
the magnitude of the entropic cost that is proposed to explain it.
Recent state-of-the-art computational estimates of the entropy
lost due to folding of the protein backbone put that value at
1.0–1.5 kcal/mol/residue (Baxa et al., 2014), while somewhat
higher estimates of the conformational entropy loss that accom-
panies disordered protein interactions have been inferred from
changes in nuclear magnetic resonance relaxation rates and
from calorimetric measurements (Bracken et al., 1999). In
contrast, the affinity difference observed here equates to a free
energy difference of only 0.1 kcal/mol/residue over a typical
nine-residue disordered epitope (see below, Figure 2). Alterna-
tively, we may compare the 5-fold difference in affinity seen
here with the 104-fold loss of affinity observed when one partner
of a high-affinity protein-protein interaction becomes disordered
(Papadakos et al., 2015). Thus, it is clear that antibodies recog-
nizing disordered epitopes are able to compensate very effec-
tively for the entropy loss that accompanies binding.
Disordered Epitopes Are Smaller than Ordered Epitopes
Studies of the interactions between disordered proteins and their
binding partners have revealed that these interactions typically
involve a larger interface surface area than do the interactions
between ordered proteins (Meszaros et al., 2007; Wong et al.,
2013). This may be a mechanism to compensate for the entropic150 Structure 24, 148–157, January 5, 2016 ª2016 Elsevier Ltd All rigcost of binding a disordered protein, as the larger interface offers
greater opportunity for favorable enthalpic or solvent-driven
contributions to binding. To examine whether this also applies
to the interactions of antibodies with disordered epitopes, we
assembled a dataset of 872 structures of antibodies in complex
with protein antigens, and predicted epitope disorder using
IUPred, as before. A total of 69 of these complexes involved epi-
topes in which all residues are predicted to be disordered, and
the remaining epitopes are classed as ordered. We compared
the sizes of the interfaces made by antibodies with ordered
and disordered epitopes. We find that disordered epitopes are
in fact substantially smaller than ordered epitopes, in terms of
both the number of residues in contact with antibody (Figure 2A)
and the buried surface area (Figure 2B). Likewise, paratopes
cognate to disordered epitopes are smaller in area and in
number of residues than is the case for paratopes to ordered
epitopes. A typical disordered epitope comprises nine residues
and makes contact with 21 paratope residues on the antibody,
burying 695 and 512 A˚2 on the antigen and antibody, respec-
tively. In contrast, the median ordered epitope comprises 21
residues in contact with a 24-residue paratope and buries 847
and 788 A˚2, respectively. Thus, in contrast to the interfaces be-
tween disordered proteins and their physiological binding part-
ners, the interfaces between disordered epitopes and their
cognate antibodies are small in area and involve relatively few
residues. In this respect, disordered epitopes appear to be
more similar to the peptide-protein interactions characterized
by London et al. (2010), in which average interface surface areas
of 512 ± 177 A˚2 were observed.
We also examined the epitope span, the minimum number of
contiguous residues that encompass all of the epitope, as a
measure of the size of the structurally intact epitope (Figure 2C).
Ordered epitopes show a bimodal distribution of epitope span; a
small group of epitopes with spans <20 residues corresponding
to simple linear epitopes, and a larger group with much longer
spans corresponding to conformational epitopes. Disordered
epitopes in this structural dataset are exclusively in the linearhts reserved
Figure 3. Affinity Maturation Is Not Impeded by Epitope Disorder
Histogram of the number of V-gene mutations inferred for each chain of anti-
bodies against ordered (blue) and disordered epitopes (red).class, disordered conformational epitopes being entirely absent.
This is consistent with expectation, and with our observations
across an extensive panel of antibodies against the disordered
malaria antigen, merozoite surface protein 2 (MSP2) (Adda
et al., 2012). We note, however, that residual disorder in disor-
dered conformational epitopes may impede crystallization and,
accordingly, such epitopes, to the extent that they might exist,
may be underrepresented in this structural dataset.
Antigen Disorder Does Not Affect Affinity Maturation of
Cognate Antibodies
It has been suggested that antigen disorder may have implica-
tions for affinity maturation (Anders, 1986; MacRaild et al.,
2015; Penkett et al., 1998), the process bywhich B-cell receptors
develop affinity and specificity for a specific antigen through so-
maticmutation as theymature into antibodies. To test for this, we
compared the sequences of the murine antibodies in our struc-
tural dataset with those of germline V-gene sequences using
IgBlast (Ye et al., 2013), and used the number of inferred V-
gene somatic mutations as a proxy for the extent of affinity matu-
ration. We find no evidence for an effect of antigen disorder on
the number of somatic mutations (Figure 3), indicating that, at
least by this measure, affinity maturation is not compromised
by antigen disorder.
Disordered Epitopes Are Enveloped by Concave
Paratopes
Figure 2B suggests that, on average, a larger surface area is
buried on disordered antigens than is buried on their cognate an-
tibodies, implying a tendency for the paratopes that recognize
disordered antigens to be concave. Previous work has demon-
strated that the topology of antibody paratopes depends to
some extent on the nature of the antigen (MacCallum et al.,
1996). We therefore examined the paratope geometry of the anti-
bodies in our structural database. The ratio of buried surface area
on the antibody to buried surface area on the antigen is signifi-
cantly lower for disordered epitopes than it is for ordered epitopes
in our dataset (Figure 4A). For ordered epitopes the median value
of this ratio is 0.93, equivalent to an effective radius of curvature of
39 A˚, and for more than 25% of ordered epitopes this ratio is >1,Structure 24, 14indicating a convex paratope. In contrast, this ratio is <1 for all
disordered epitope complexes in the dataset, suggesting that
paratopes cognate to disordered epitopes may always be con-
cave, and themedian value for disordered epitopes is 0.74, equiv-
alent to an effective radius of curvature of 9 A˚. Paratope topology
is determined, at least in part, by variations in complementarity-
determining region (CDR) length (Collis et al., 2003), and accord-
ingly we find that the average length of CDRsH2, H3, and L1 differ
significantly between antibodies recognizing ordered and disor-
dered antigens (Figure 4B). In antibodies to disordered antigens,
the central CDR H3 is shorter, and the flanking CDRs H2 and L1
are longer, consistent with the concave topology inferred from
comparison of buried surface areas.
Consistent with this strong tendency for concave paratope to-
pology, we observe that the average surface area buried on indi-
vidual paratope and epitope residues is dependent on the nature
of the epitope (Figure 4C). Disordered epitopes bury, on average,
24.1 A˚2 of antibody surface per paratope residue, significantly
less than the 32.8 A˚2 per paratope residue buried by ordered
epitopes. In contrast, the area buried per residue in the antigen
shows the opposite trend, with disordered epitopes burying
75.6 A˚2 per residue, much more than the 44.9 A˚2 per residue
buried by ordered epitopes. Together, these data suggest a
more intimate interaction between disordered antigens and
their antibodies, in which a smaller epitope is more completely
buried within the concave paratope. Consistent with this interpre-
tation, the interface shape complementarity between disordered
epitopes and their cognate paratope is higher than it is for ordered
epitopes (Figure 4D). Similarly, peptide-protein interfaces appear
better packed than do protein-protein interfaces (London et al.,
2010), as measured by the RossettaHoles packing score.
Structural Basis for the Unexpectedly High Affinity of
Antibodies to Disordered Epitopes
The data in Figures 2 and 4 show that disordered epitopes
are small, but have much more extensive contacts per epitope
residue and better shape complementarity with their cognate
antibody than do ordered epitopes. As proposed previously for
peptide-protein interactions (London et al., 2010), this suggests
a possible explanation for the unexpected efficiency with which
these antibodies compensate for the large entropic cost of bind-
ing to a disordered epitope. By limiting the number of residues
involved in the epitope this entropic cost is minimized, while by
maximizing the extent and complementarity of the interaction
the compensating enthalpic component of the binding free en-
ergy is optimized.
To explore this further, we cross-referenced the antibody-an-
tigen binding affinities reported in the IEDB with our structural
dataset by matching antibody names and epitope identifiers in
the respective IEDB records. In this way, we assigned 357 exper-
imentally determined Kd values to the corresponding antibody-
antigen complex structures. We confirmed that the affinities in
this structural dataset are similar to those observed for the
sequence-based antigen dataset (compare Figures 1D and
5A). We also compared the free energy of binding as a fraction
of the buried surface area on the antibody and the antigen
(Figure 5B) and of the number of antibody and antigen con-
tact residues (Figure 5C). By both measures, the interactions of
disordered epitopes are more efficient: they gain almost 30%8–157, January 5, 2016 ª2016 Elsevier Ltd All rights reserved 151
Figure 4. Disordered Epitopes are Recog-
nized by Concave Paratopes
(A) The ratio of buried surface area on the antibody
(Ab) to the buried surface area on the antigen (Ag) is
lower for disordered epitopes (red) than for ordered
epitopes (blue). Exemplar ordered and disordered
antigen-antibody interfaces with typical surface
area ratios are shown: hen egg lysozyme (blue) with
antibody HyHEL-63 (PDB: 1NBZ) (Li et al., 2003)
and a Neisseria meningitidis PorA disordered vari-
able epitope (red) with antibody MN14C11.6 (PDB:
1QKZ) (Derrick et al., 1999).
(B) The length of antibody CDR loops differs be-
tween ordered (blue) and disordered epitopes
(red). CDR locations are shown on the antibody
6D8 bound to a conserved epitope of the disor-
dered malaria antigen merozoite surface protein 2
(PDB: 4QYO) (Morales et al., 2015).
(C) Disordered epitopes (red) bury less surface area
per residue on the cognate antibody (left) than or-
dered epitopes (blue), whereas on the antigen
(right), more surface area per epitope residue is
buried where the epitope is disordered.
(D) Shape complementarity of the interface be-
tween antibodies and their disordered epitopes
(red) is greater than it is with ordered epitopes
(blue).
Boxplots show the median (horizontal line) and in-
terquartile range (box), with whiskers extending to
1.5 times the interquartile range, and any outlying
points plotted.more binding free energy for each unit area of antibody buried,
and gain almost twice the free energy per antigen residue in con-
tact with antibody. There is a modest but highly significant corre-
lation between binding affinity and total interface surface area for
ordered antigens (Spearman’s r = 0.29, p = 93 108), consistent
with an extensive body of literature on diverse classes of protein
interactions (Chen et al., 2013; Lo Conte et al., 1999; Myslinski
et al., 2011; Spolar et al., 1989). Remarkably, that correlation ap-
pears to be absent for disordered antigens (Spearman’s r =
0.005), although this difference in correlation does not reach152 Structure 24, 148–157, January 5, 2016 ª2016 Elsevier Ltd All rights reservedformal significance over the relatively
small number of disordered antigens
for which affinities are available (n = 26,
p = 0.08 by permutation test). We also
observe a significant correlation between
interface shape complementarity and the
binding free energy per unit total buried
surface area (Spearman’s r = 0.40, p =
13 109 over the full dataset), suggesting
that shape complementarity may be an
important mechanism by which anti-
bodies to disordered epitopes achieve
their binding efficiency. Strikingly, how-
ever, there is no correlation between
shape complementarity and overall affin-
ity (Spearman’s r = 2 3 104).
Hydrogen bonds and salt bridges are
known to be enriched in the interfaces of
disordered proteins with ordered bindingpartners (Wong et al., 2013), and in peptide-protein interactions
(London et al., 2010). Accordingly, we examined the abundance
of these polar contacts in the current structural dataset. In
contrast to these previous results in related systems, we find
fewer intermolecular polar contacts, in absolute terms, in anti-
body-antigen complexes involving disordered epitopes than in
complexes involving ordered antigens (Table 1). Nonetheless,
because of the smaller size of the complexes of disordered anti-
gens, the density of these contacts is higher; residues within
disordered epitopes are more than 50% more likely to be
Figure 5. Antibodies Bind Disordered Epitopes with Greater Efficiency
(A) The affinity of antibodies in our structural dataset differs only slightly between ordered (blue) and disordered (red) epitopes.
(B) Antibodies to disordered epitopes (red) obtain more binding free energy per unit of buried surface area on the antibody (left) than do antibodies to ordered
epitopes (blue). No such difference is seen in binding free energy per unit of buried antigen surface (right).
(C) Antibodies to disordered epitopes (red) gain less binding free energy per contact residue in the antibody (left) than do antibodies to ordered epitopes (blue), but
more energy per contact residue in the antigen (right).
Boxplots show the median (horizontal line) and interquartile range (box), with whiskers extending to 1.5 times the interquartile range, and any outlying points
plotted.involved in a salt bridge and twice as likely to be involved in a
hydrogen bond with the antibody compared with residues in or-
dered antigens.
Implications for the Specificity of Antibody Recognition
by Disordered Antigens
The preceding results establish that disordered epitopes are
intimately enveloped by their cognate antibody, making more
efficient use of a limited interface to generate high binding
energies. This may have implications for the specificity of the
interactions between disordered antigens and their cognate an-
tibodies. In particular, we predict that the more extensive con-
tacts made by each residue of a disordered epitope will make
antibody recognition of disordered antigens more sensitive to
sequence variation within the epitope. To test this hypothesis,
we have performed computational alanine scans on each of
the structures in our dataset to estimate the consequences of
mutating each interface residue for the affinity of the complex.
The consequences of mutations of paratope residues are rela-
tively insensitive to the degree of order in the cognate epitope
(Figure 6A). In contrast, mutations within disordered epitopes
are much more frequently associated with a significant unfavor-
able change in binding affinity (i.e. a large positive value of
DDG, Figure 6B).
It is widely recognized that a few key residues make domi-
nant contributions to the binding energy of protein-protein in-
teractions (Bogan and Thorn, 1998; Clackson and Wells,
1995). These ‘‘hot-spot’’ residues are thus the key determi-
nants of binding affinity and specificity. We find that the para-
topes of antibodies to disordered epitopes are slightly
depleted in hot-spot residues (defined as residues with a pre-
dicted DDG > 1.5 kcal/mol), relative to those of antibodies
recognizing ordered epitopes (Figure 6C, left). In contrast,
disordered epitopes are heavily enriched in hot-spot residues,
with disordered epitope residues almost twice as likely as or-
dered epitope residues to be hot spots (Figure 6C, right).
These data suggest that epitope polymorphisms are more
likely to modulate antibody recognition in disordered epitopes
than in ordered epitopes.Structure 24, 14DISCUSSION
Disordered antigens are important targets of natural immune re-
sponses to a number of pathogens, and are increasingly attract-
ing attention as potential vaccine components (Adda et al., 2012;
Foquet et al., 2014; Foucault et al., 2010; Olugbile et al., 2009;
Raj et al., 2014; Yagi et al., 2014). In spite of this, little is known
about the implications of conformational disorder for the devel-
opment of an effective immune response. Indeed, it is widely
speculated that conformational disorder may impede the devel-
opment of a high-affinity and specific antibody response (An-
ders, 1986; Dunker et al., 2002; Kemp et al., 1987; Kwong
et al., 2002; MacRaild et al., 2011, 2015). The results presented
here suggest otherwise: disordered proteins appear to be more
antigenic than ordered proteins, reflecting the greater exposure
of disordered regions to solvent (and hence to recognition by an-
tibodies) (Figures 1B and 1C). Likewise, the difference in the af-
finities of the interactions made by antibodies with ordered and
disordered epitopes is very much smaller than might be ex-
pected, given the large, unfavorable entropic contribution arising
from the disorder-order transition that necessarily accompanies
binding (Figure 1D). Indeed, antibodies bind disordered epitopes
with higher efficiency than ordered epitopes, in the sense that
they achieve more binding free energy per unit of interface sur-
face area, or per epitope residue (Figure 5). This efficiency is pre-
sumably driven by the need to minimize the extent of disordered
epitopes, and thus minimize the entropic cost of inducing order.
Our analysis of the structures of disordered epitopes in com-
plex with antibodies reveals features of these interactions that
may contribute to this increase in binding efficiency. We find
that disordered epitopes tend to bind deep within concave para-
topes, burying a much larger proportion of each interacting res-
idue than do ordered epitopes (Figure 4). Moreover, they show
greater shape complementarity with their cognate antibody,
and possess a greater density of intermolecular polar contacts
(Figure 5 and Table 1). This may reflect the flexibility of disor-
dered proteins and their consequent ability to better adapt to
the shape of their binding partner. Indeed, this flexibility permits
some disordered epitopes to adopt distinct conformations8–157, January 5, 2016 ª2016 Elsevier Ltd All rights reserved 153
Figure 6. Antibody Recognition of Disordered Epitopes IsMore Sen-
sitive to Mutation
(A) The distribution of predicted changes in binding free energy when residues
in the antibody paratope are mutated to Ala is similar for ordered (blue) and
disordered (red) epitopes.
(B) The distribution of predicted changes in binding free energy when residues
in the epitope are mutated to Ala differs for ordered (blue) and disordered (red)
epitopes.
(C) Hot-spot residues (DDG > 1.5 kcal/mol, shaded region in A and B) are less
frequent in antibodies (left) to disordered (red) than ordered epitopes (blue),
whereas they aremore frequent in disordered epitopes (red, right). FoldX results
for exemplar ordered and disordered epitopes with typical hot-spot density are
shown: the ordered rhuMAb-VEGF epitope on vascular endothelial growth
factor (PDB: 1CZ8) (Chen et al., 1999) (bottom), and a disordered epitope from
the preS antigen of human hepatitis B virus (PDB: 2EH8) (Chi et al., 2007) (top).
Boxplots show the median (horizontal line) and interquartile range (box), with
whiskers extending to 1.5 times the interquartile range, and any outlying points
plotted.
Table 1. Disordered Epitopes Are Enriched in Polar Contacts
with Antibody
Ordered Disordered p
H bonds 9.1 ± 0.2 7.8 ± 0.4 0.007
Per 100 A˚2 1.11 1.32 0.002
Per Ag residue 0.52 1.0 6 3 1016
Salt bridges 1.73 ± 0.05 1.55 ± 0.2 NS
Per 100 A˚2 0.22 0.26 NS
Per Ag residue 0.11 0.18 0.002
NS, not significant.bound to different antibodies (Chu et al., 2014; Deng et al., 2014).
Additional factors outside the scope of the current datasets may
also be at play here; for example, we are unable to assess the
extent to which residual structure exists within otherwise disor-
dered epitopes, which may reduce the entropic cost of binding
(Borcherds et al., 2014). Likewise, the extent to which transient
or ‘‘fuzzy’’ interactions modulate the affinities characterized
here is unknown (Fuxreiter and Tompa, 2012), although in at least
one instance fuzzy interactions do appear to modulate the affin-
ity and specificity with which an antibody recognizes its disor-
dered antigen (Morales et al., 2015).
These caveats notwithstanding, similar observations have
been made for the interactions that peptides and disordered
proteins make with other binding partners (London et al., 2010;
Meszaros et al., 2007; Wong et al., 2013), suggesting that the
strategies of concave binding sites, high surface complemen-
tarity, and dense polar contacts may contribute to the interac-
tions of disordered proteins more generally. They are, however,
particularly pronounced in the current dataset, for at least two
reasons. First, B cells mature under strong selective pressure
for affinity to antigen, meaning that the antibody-antigen interac-
tions studied here are selected for optimal affinity to an extent
that may not apply to the interactions of disordered proteins in
other contexts (Zhou, 2012). Second, whereas the interfaces
disordered proteins make with antibodies are small (Figure 2),
limited by the extent of both the disordered epitope and antibody
paratopes generally, the interfaces that disordered proteins
make with other protein binding partners are often much larger
(Wong et al., 2013), limiting the need for the extreme spatial effi-
ciency seen here.
Very recently, we showed that the most flexible regions of the
highly disordered malaria antigen MSP2 were less immunogenic
than slightly more constrained regions (MacRaild et al., 2015).
Based on this we hypothesized that, in the context of disordered
antigens, intermediate levels of flexibility may be optimal for
immunogenicity. Although we find no clear support for this hy-
pothesis in the current analysis, direct comparison with our
data on MSP2 is challenging because MSP2 has a uniformly
high IUPred score (>85% of residues score >0.8), leading to
weak correlation between IUPred score and the experimental
measures of conformational flexibility analyzed in our prior work.
The implications of conformational disorder for the specificity
of protein interactions remain a matter of active debate (Haynes
et al., 2006; Huang and Liu, 2013; Schnell et al., 2007; Tokuriki
and Tawfik, 2009a; Zhou, 2012). We have shown that individual
residues of disordered epitopes are more likely to be energeti-154 Structure 24, 148–157, January 5, 2016 ª2016 Elsevier Ltd All rigcally important for recognition by antibody than their counter-
parts in ordered epitopes. Very similar observations have been
made for other interactions involving disordered proteins and
peptides (Chen et al., 2013; Wong et al., 2013), suggesting
that, in general, interactions with disordered proteins may be
more sensitive to mutation in the disordered partner, and in
that sense more specific than the interactions of ordered pro-
teins. One striking observation from the data presented here is
the asymmetry seen between antibody and antigen in measures
of binding efficiency (Figure 5) and the distribution of hot-spot
residues (Figure 6). While disordered epitopes contribute more
binding energy per residue than do ordered epitopes, the oppo-
site trend holds (albeit weakly) for their cognate antibodies; simi-
larly, hot-spot residues are enriched within disordered epitopes
but depleted within their cognate paratopes when compared
with their ordered counterparts. Again, there is evidence for
such asymmetry in the interactions of disordered proteins
more broadly (Meszaros et al., 2007; Wong et al., 2013). This im-
plies that, while the recognition of disordered proteins may be
particularly sensitive to sequence variation in the disordered
binding partner, it will be relatively insensitive to variation in the
ordered binding partner. In other words, the effects of disorder
on specificity may themselves be asymmetric, being dependenthts reserved
on which side of the protein complex variation occurs. It is not
clear that this asymmetry has been recognized in previous at-
tempts to address the interplay of conformational disorder and
specificity (Huang and Liu, 2013). It is striking, also, to contrast
the clear differences in the distribution of stability effects of
mutations observed here (Figures 6A and 6B) to the uniform dis-
tribution of the effects of mutations on the stability of globular
proteins (Tokuriki et al., 2007). The distribution of mutation ef-
fects has implications for protein evolvability (Tokuriki and Taw-
fik, 2009b); it is likely, therefore, that these differences contribute
to the distinct patterns of sequence evolution seen in the interac-
tion motifs of disordered proteins (Brown et al., 2011).
Disordered proteins and regions of low sequence complexity
are particularly abundant in a range of pathogenic species
(Feng et al., 2006; Pizzi and Frontali, 2001; Xue et al., 2014),
and the consequences of this disorder for antigenic responses
to these pathogens have been the subject of extensive specula-
tion (Kemp et al., 1987; Ridley, 1991; Zilversmit et al., 2010).
The results presented here demonstrate that disordered epi-
topes are bona fide targets of high-affinity and specific antibody
responses. They imply that the entropic cost of binding to a
disordered epitope is in itself no barrier to the development of
a high-affinity and specific antibody response, in contrast to
some suggestions (Kwong et al., 2002; MacRaild et al., 2015;
Penkett et al., 1998). Indeed, they suggest that antibody recog-
nition of disordered antigens is likely to be particularly sensitive
to polymorphism in the antigen sequence. Disordered regions
in protein antigens are also frequently more polymorphic than or-
dered regions; our findings suggest that the effects of some of
these polymorphisms on antibody recognition may be particu-
larly acute. It is possible, therefore, that the abundance of disor-
dered proteins in some pathogens is, to an extent, due to the
tolerance of these proteins for sequence variation that will be
particularly effective in enabling the evasion of recognition by
antibodies.
EXPERIMENTAL PROCEDURES
Linear Peptide Epitopes from the Immune Epitope Database
From the IEDB, we extracted antibody binding assays involving linear peptide
epitopes. From these assays we retained those involving antigens for which
five or more assay records are available and for which we could determine
the complete antigen sequence, giving a final dataset of 105,235 antibody
binding assays covering 54,293 unique epitopes on 1,946 antigens. Affinity
measurements are reported for 666 binding assays covering 284 of these epi-
topes (Dataset S1). IUPred scores (Dosztanyi et al., 2005) were calculated over
the full sequence of each antigen, and epitopes were classified as ‘‘disor-
dered’’ if the IUPred score was R0.5 for all residues within the epitope and
for five flanking residues on each side, ‘‘ordered’’ if the IUPred score was
<0.5 for all such residues, and ‘‘mixed’’ otherwise.
The relationship between IUPred score and solvent exposure was estimated
from a non-redundant selection of chains extracted from the PDB (Berman
et al., 2002), using IUPred and DSSP (Kabsch and Sander, 1983) as described
in Supplemental Experimental Procedures.
Structural Analysis of Disordered Antigen-Antibody Interactions
We extracted 872 structures from the PDB based on IEDB records describing
three-dimensional structures of antibody complexes with protein or peptide
antigens. Binding affinities for each antibody-antigen complex were extracted
from the IEDB by cross-referencing the IEDB epitope ID and antibody name
from each three-dimensional structure record with records reporting quantita-
tive binding affinities. Where multiple affinities were reported for a single com-Structure 24, 14plex, we used the mean of the pKd values (Dataset S2). SASA and secondary
structures were determined using DSSP, shape complementarity of the
antibody-antigen interface was assessed with the Sc statistic (Lawrence and
Colman, 1993), and hydrogen bonds between antigen and antibodywere iden-
tified using HBPlus (McDonald and Thornton, 1994) using default parameters.
Further details of the analysis are presented in Supplemental Experimental
Procedures.
For the inference of somatic V-gene mutations, the antibody sequences
as reported in the PDB SEQRES field were compared with the appropriate
IMGT germline V-gene reference dataset using IgBlast (Ye et al., 2013). Sig-
nificant species-specific differences in the number of V-gene mutations
were observed, so the dataset was segregated by species. However, there
were insufficient sequences available for a robust analysis for species other
than Mus musculus, so only murine antibodies are included in the final
analysis.
Computational alanine scans were performed using FoldX 3.0 beta 6.1
(Schymkowitz et al., 2005) The FoldX RepairPDB command was run first, to
optimize the complex conformation under the FoldX force field, followed by
the complex_alascan command. All parameters were maintained at default
values except <VdWDesign>, which was set to 0 for the complex_alascan
procedure. We define hot-spot residues as those with predicted DDG >
1.5 kcal/mol.
Statistical Analysis
Comparisons between classes were performed using the Wilcoxon rank-sum
test, except for the comparisons between CDR lengths, which used bootstrap
resampling to test for differences in the mean.
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